Literature DB >> 17846306

Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery.

Najmeddine Echahidi1, Dania Mohty, Philippe Pibarot, Jean-Pierre Després, Gilles O'Hara, Jean Champagne, François Philippon, Pascal Daleau, Pierre Voisine, Patrick Mathieu.   

Abstract

BACKGROUND: Postoperative atrial fibrillation (POAF) is a highly prevalent complication after cardiac surgery with substantial effects on outcomes. Previous studies have reported that obesity is a risk factor for POAF after cardiac surgery. However, it is unknown whether the metabolic syndrome (MS) also increases the risk of postoperative atrial fibrillation. METHODS AND
RESULTS: We retrospectively analyzed the association between obesity and MS and the incidence of new-onset POAF in a total of 5085 patients who underwent isolated coronary artery bypass grafting surgery with no concomitant valvular surgery. Of these patients, 1468 (29%) were obese (body mass index > or = 30 kg/m2) and 2320 (46%) had a MS as defined by the NCEP-ATPIII. POAF occurred in 1374 (27%) of the patients. Obesity was associated (P<0.001) with increased incidence of POAF in the whole cohort as well as in patients > 50 years old but not in patients < or = 50 years old. In these patients, MS was the only metabolic factor to be significantly associated with higher incidence of POAF (12% versus 6%, P=0.01). In > 50-year-old patients, mild (30 < or = body mass index < 35 kg/m2) and moderate-severe (body mass index > or = 35 kg/m2) obesity were independently associated with a 1.4-fold (95% CI: 1.10 to 1.71; P=0.004) and 2.3-fold (95% CI: 1.71 to 3.13; P<0.0001) increase in the risk of POAF, respectively. In < or = 50-year-old patients, MS (relative risk [RR]: 2.36; 95% CI: 1.10 to 5.12; P=0.02) but not obesity was independently associated with POAF.
CONCLUSIONS: This study demonstrates that obesity is a powerful risk factor for the occurrence of POAF after isolated coronary artery bypass grafting surgery in patients older than 50 years. However, in the younger population, this association is not observed and MS is the only metabolic risk factor to be independently associated with POAF.

Entities:  

Mesh:

Year:  2007        PMID: 17846306     DOI: 10.1161/CIRCULATIONAHA.106.681304

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

1.  Quantitative electrocardiography for predicting postoperative atrial fibrillation after cardiac surgery.

Authors:  Florian Rader; Otto Costantini; Craig Jarrett; Eiran Z Gorodeski; Michael S Lauer; Eugene H Blackstone
Journal:  J Electrocardiol       Date:  2011-01-26       Impact factor: 1.438

2.  Obesity begets atrial fibrillation: a contemporary summary.

Authors:  Jared W Magnani; Elaine M Hylek; Caroline M Apovian
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

3.  Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Alanna M Chamberlain; Sunil K Agarwal; Marietta Ambrose; Aaron R Folsom; Elsayed Z Soliman; Alvaro Alonso
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

Review 4.  Obesity Surgery and Anesthesiology Risks: a Review of Key Concepts and Related Physiology.

Authors:  Sjaak Pouwels; Marc P Buise; Pawel Twardowski; Pieter S Stepaniak; Monika Proczko
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

Review 5.  New-onset atrial fibrillation: an update.

Authors:  Takeshi Omae; Eiichi Inada
Journal:  J Anesth       Date:  2018-03-09       Impact factor: 2.078

6.  Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome.

Authors:  Michael W Manning; Mary Cooter; Joseph Mathew; John Alexander; Eric Peterson; T Bruce Ferguson; Renato Lopes; Mihai Podgoreanu
Journal:  Ann Thorac Surg       Date:  2017-01-25       Impact factor: 4.330

Review 7.  Catheter Ablation of Atrial Fibrillation in Overweight and Obese Patients.

Authors:  Louiza Lioni; Panagiotis Korantzopoulos; Konstantinos P Letsas
Journal:  J Atr Fibrillation       Date:  2011-12-20

8.  Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery.

Authors:  Gregory A Fleming; Katherine T Murray; Chang Yu; John G Byrne; James P Greelish; Michael R Petracek; Steven J Hoff; Stephen K Ball; Nancy J Brown; Mias Pretorius
Journal:  Circulation       Date:  2008-09-29       Impact factor: 29.690

Review 9.  Targeting abdominal obesity in cardiology: can we be effective?

Authors:  Paul Poirier
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

Review 10.  Abdominal obesity and the metabolic syndrome: a surgeon's perspective.

Authors:  Patrick Mathieu
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.